Artwork

Content provided by Fox News Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fox News Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The FDA Rejects MDMA...What Now?

11:58
 
Share
 

Manage episode 422258915 series 2813395
Content provided by Fox News Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fox News Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

After much deliberation, this week a panel of experts advising the Food and Drug Administration voted against the approval of therapy-guided MDMA for treating PSTD.

Kennedy criticizes the panel for prohibiting PSTD patients from getting effective treatment and highlights the success of studies and clinical trials conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS) and the high improvement rates reported by participants.

Follow Kennedy on Twitter: @KennedyNation

Kennedy Now Available on YouTube: https://bit.ly/4311mhD.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

528 episodes

Artwork
iconShare
 
Manage episode 422258915 series 2813395
Content provided by Fox News Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fox News Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

After much deliberation, this week a panel of experts advising the Food and Drug Administration voted against the approval of therapy-guided MDMA for treating PSTD.

Kennedy criticizes the panel for prohibiting PSTD patients from getting effective treatment and highlights the success of studies and clinical trials conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS) and the high improvement rates reported by participants.

Follow Kennedy on Twitter: @KennedyNation

Kennedy Now Available on YouTube: https://bit.ly/4311mhD.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

528 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide